Melissa Reyes

United States Food and Drug Administration

Also affiliated with Center for Drug Evaluation and Research, Food and Drug Administration

MedicinePharmacology, Toxicology and Pharmaceutics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Cosmetic disfigurement from black salve”.

Cosmetic disfigurement from black salve

Drugs & Therapy Perspectives(2020)10.1007/s40267-020-00775-1

N/A

0DataRank · unranked

4 citations

Karen Konkel, Ida-Lina Diak, Melissa Reyes, Lynda McCulley, Lopa Thambi

Teriparatide-associated calciphylaxis: a case series

Osteoporosis International(2021)10.1007/s00198-021-06139-3

N/A

0DataRank · unranked

12 citations

Karen Konkel, S. Christopher Jones, Melissa Reyes, Lynda McCulley, Jenny Jane Kim

Updates in SJS/TEN: collaboration, innovation, and community

Frontiers in Medicine(2023)10.3389/fmed.2023.1213889

N/A

0DataRank · unranked

34 citations

Ramya Krishna Botta, Riichiro Abe, Thomas M. Beachkofsky, Isabelle Boothman, Bruce Carleton +57 more

Executive summary: Consensus treatment guidelines for the use of methotrexate for inflammatory skin disease in pediatric patients

Journal of the American Academy of Dermatology(2024)10.1016/j.jaad.2023.12.074

N/A

0DataRank · unranked

2 citations

Lisa M. Arkin, Yvonne E. Chiu, Adelaide A. Hebert, Jeffrey P. Callen, Leslie Castelo‐Soccio +22 more

FDA Adverse Event Reporting System (FAERS) Essentials: A Guide to Understanding, Applying, and Interpreting Adverse Event Data Reported to FAERS

Clinical Pharmacology & Therapeutics(2025)10.1002/cpt.3701

N/A

0DataRank · unranked

86 citations

Melissa Reyes, Jennifer L. Greene-Naples, Gerald J. Dal Pan, E. Lake Potter

Response to FDA Adverse Event Reporting System (FAERS) Essentials: A Reflection on Study Conception

Clinical Pharmacology & Therapeutics(2025)10.1002/cpt.70040

N/A

0DataRank · unranked

0 citations

E. Lake Potter, Gerald J. Dal Pan, Melissa Reyes